A U.S. Marine Corps MV-22 Osprey lands aboard the Royal Australian Navy landing helicopter dock HMAS Canberra during the Rim of the Pacific exercise in 2022. (Leading Seaman Matthew Lyall/Royal ...

Wezlana is the first biosimilar to reference Stelara approved in the United States. The product will launch in 2025. FDA has approved the first ustekinumab (Stelara) biosimilar in the United States.

PHILADELPHIA -- Pfizer has made the case for gaining the coveted "interchangeability" status for its adalimumab biosimilar (Abrilada), a study presented here suggested. A pivotal trial involving ...

The FDA has already approved 4 biosimilars in the United States, but there remains a lot of uncertainty surrounding some of the legislation and regulation. The FDA has already approved 4 biosimilars ...

Credit: Celltrion. The FDA originally approved Stoboclo and Osenvelt as biosimilars in March 2025. The interchangeability designation allows Stoboclo and Osenvelt to be substituted at the pharmacy for ...

Knock-off versions of biotech drugs have been on the market for several years now, but one way that the US market for biosimilars has lagged behind its European counterpart is on the question of ...

Basic components designed for single-use in bioprocessing aren’t as interchangeable as biomanufacturers often assume. Subtle differences in components contribute to greater process variability, ...

One of the biggest issues the National Fire Protection Association (NFPA) Technical Committee on Respiratory Protection Equipment has struggled with during the current revision cycle of NFPA 1981, ...